Schrödinger

Schr??dinger Announces Acquisition of XTAL BioStructures, Inc.

NEW YORK--(BUSINESS WIRE)--Jan. 18, 2022-- Schrˆdinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the acquisition of XTAL BioStructures, Inc., a private company based in the Greater Boston area that provides structural biology services, including biophysical methods, protein production and purification, and X-ray crystallography, to...
1540 Broadway 24th Floor New York, NY 10036

+1 212 295 5800